Efektivitas Ondansetron ebagai Profilaksis Mual dan Muntah pada Pasien Kanker Payudara Stadium 3 Pasca Kemoterapi

Ariyani, Agustina Fitri and Purnamayanti, Anita and Kirtishanti, Aguslina (2022) Efektivitas Ondansetron ebagai Profilaksis Mual dan Muntah pada Pasien Kanker Payudara Stadium 3 Pasca Kemoterapi. Journal of Islamic Pharmacy, 7 (1). pp. 41-45. ISSN 2527-6123

PDF Anita Purnamayanti_Efektivitas Ondansetron.pdf Download (1MB)

Abstract

Chemotherapy is one of the therapies used to reduce the risk of cancer cells metastases. Based on the mechanism of the chemotherapy is an anti-neoplastic which is toxic to the cancer and the normal cells. The adverse effects of chemotherapy consist of myelosuppression, as well as nausea and vomiting. Therefore, patients are given prophylaxis antiemetics to prevent and reduce chemotherapy-induced nausea and vomiting (CINV). The aim of the study was to analyze the effectiveness of ondansetron as prophylaxis of nausea and vomiting in breast cancer patients. The design of this study was cohort observational study conducted prospectively. Stadium 3 without metastases breast cancer patients aged 20-80 years old who had been administered with one of combination of cytotoxic regiments for 6 cycles on the first chemotherapy serial were enrolled in this study. We excluded breast cancer patients who were refused to be included in this study. The drop out criteria was patients who passed away before completing the full cycles. There were 76.7% subject of the study who experienced nausea or vomiting during and post chemotherapy, despite of ondansetron has been taken 8 mg orally in the full 6 cycles of the therapies. The result of the multivariate test was that effectiveness of ondansetron in preventing CINV was not affected by body mass index (BMI) and age grouping (p=0.501). It could be concluded that the effectiveness of ondansetron in preventing CINV was not affected by the BMI as well as patients’ age. Keywords: chemotherapy, antiemetics, breast cancer

Item Type:	Article
Uncontrolled Keywords:	chemotherapy, antiemetics, breast cancer
Subjects:	R Medicine > RS Pharmacy and materia medica
Divisions:	Faculty of Pharmacy > Department of Pharmacy
Depositing User:	Agustina Fitri Ariyani
Date Deposited:	15 Aug 2022 07:26
Last Modified:	17 Feb 2023 04:39
URI:	http://repository.ubaya.ac.id/id/eprint/42324

Actions (login required)

View Item